Latest Period
Q2 2026
Security Snapshot
ATOSSA THERAPEUTICS, INC. - COM (ATOS) Institutional Ownership
CUSIP: 04962H704
13F Institutional Holders and Ownership History from Q4 2025 to Q2 2026
Institutions Reporting
30
Shares (Excl. Options)
1,345,277
Price
$1.93
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COM
- Symbol
- ATOS on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 1,345,277
- Total 13F value
- $2,596,510
- Portfolio coverage rank
- 0%
- Share change
- +105,309
- Value change
- +$197,842
- Number of holders
- 30
- SEC-reported price per share
- $2.31
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
1 identity field
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ATOS - ATOSSA THERAPEUTICS, INC. - COM is tracked under CUSIP 04962H704.
- 30 institutions reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 33 to 30 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $6,520,004 to $2,596,510.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 30 institutions filings for Q2 2026.
Security key
04962H704
Latest holder period
Q2 2026
13F holders
30
13D/G owners
0
CIK / CUSIP context first
Open Q2 2026 holders
ATOS full holder history
ATOSSA THERAPEUTICS, INC. SEC filings
ATOSSA THERAPEUTICS, INC. company facts
ATOSSA THERAPEUTICS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 04962H704:
As of 30 Jun 2026, 30 institutional investors reported holding 1,345,277 shares of ATOSSA THERAPEUTICS, INC. - COM (ATOS).
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
3
Latest
Q2 2026
Rows shown
1-3 of 3